| Literature DB >> 30551464 |
Sai Zhao1, Wenwei Zuo2, Huaiping Chen1, Tianping Bao1, Xiangye Liu1, Tingting Sun1, Shouguo Wang3.
Abstract
The aim of present study was to evaluate the effects of the pilose antler peptide (PAP) on bleomycin (BLM)-induced lung fibrosis. The lung wet-to-dry weight (W/D) ratio and myeloperoxidase (MPO) activity were measured. The serum levels of super-oxide dismutase (SOD), malondialdehyde (MDA) were examined. Then the contents of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6 were determined using ELISA method. Furthermore, the protein expressions of Rho, ROCK1, p-IκB, IκB, p-NF-κB, NF-κB in lung tissues were detected by western blot analysis. As a result, PAP markedly decreased pulmonary W/D ratio, lung MPO activity and relieved lung histopathological changes. In addition, PAP increased the level of SOD and reduced the levels of MDA, TNF-α, IL-1β, IL-6 in serum of BLM-stimulated mice. In addition, PAP remarkably inhibited the protein levels of ROCK/NF-κB pathway. In conclusion, our results showed that PAP exhibited protective effects on pulmonary fibrosis via the regulation of ROCK/NF-κB pathway.Entities:
Keywords: Lung fibrosis; Pilose antler peptide; ROCK/NF-κB
Mesh:
Substances:
Year: 2018 PMID: 30551464 DOI: 10.1016/j.biopha.2018.08.114
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529